Improving rare disease diagnosis and outcomes through screening and scientific exchange – what can be done in the Middle East

 

Inherited disorders and congenital malformations are a leading cause of infant mortality across the Gulf region, accounting for about 40% of infant deaths in the UAE alone.1 With about 11 million infants born each year in the Middle East and North Africa region, screening for genetic disorders is a public health priority.2,    

To read the full publication, click here  https://www.openhealth.co.uk/news/04-06-2018/improving-rare-disease-diagnosis-and-outcomes-through-screening-and-scientific-exchange-what-can-be-done-in-the-middle-east/